Novavax seeks COVID-19 vaccine use in India ahead of US

Vaccine maker Novavax announced Thursday it has asked regulators in India Indonesia and the Philippines to allow emergency use of its COVID-19 vaccine -- offering its shot to developing countries before vaccine-flush rich ones. U.S.-based Novavax partnered with the Serum Institute of India to apply in the three countries, and plans later this month to also seek the World Health Organization review needed to be part of the COVAX global vaccine program. Novavax CEO Stanley Erck called the submissions an “important step toward access to millions of doses of a safe and effective vaccine for countries with an urgent need to control the pandemic.”